Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1116 of 1,261
  1. US 7018841

    Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Mar 28, 2006 Β· Expires Mar 23, 2026

    expired
  2. US 7018989

    Chemical compounds

    University College Cardiff Consultants Limited Β· Granted Mar 28, 2006 Β· Expires Mar 23, 2026

    expired
  3. US 7018465

    Aerosolized ceramic porcelains and glaze composition

    EnameLite, LLC Β· Granted Mar 28, 2006 Β· Expires Mar 23, 2026

    expired
  4. US 7018657

    Particulate composition

    University College Cardiff Consultants Limited Β· Granted Mar 28, 2006 Β· Expires Mar 23, 2026

    expired
  5. US 7019135

    Anti-viral pyrimidine nucleoside analogues

    University College Cardiff Consultants Limited Β· Granted Mar 28, 2006 Β· Expires Mar 23, 2026

    expired
  6. US 7018987

    Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Mar 28, 2006 Β· Expires Mar 23, 2026

    expired
  7. WO 2006031885

    PEPTIDES DE LIAISON A LA REGION DU DOMAINE KINASE (KDR) ET AU COMPLEXE FACTEUR DE CROISSANCE ENDOTHELIALE VASCULAIRE/REGION DU DOMAINE KINASE (VEGF/KDR)

    DYAX CORP [US] Β· Granted Mar 23, 2006 Β· Expires Mar 18, 2026

    expired
  8. US 7014847

    Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  9. US 7015212

    Thiazepine inhibitors of HIV-1 integrase

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  10. US 7015346

    Short-acting sedative hypnotic agents for anesthesia and sedation

    Theravance, Inc. Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  11. US 7015312

    Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and kits thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  12. US 7015307

    Process for purifying glycopeptide phosphonate derivatives

    Theravance, Inc. Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  13. US 7015305

    Process for preparing glycopeptide derivatives

    Theravance, Inc. Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  14. US 7015207

    Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for preventing and treating sexual disorder

    Third Military Medical University, Chinese People's Liberation Army, P.R. of China Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  15. US 7015024

    Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  16. US 7015037

    Multiponent adult stem cells and methods for isolation

    Regents of the University of Minnesota Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  17. US 7015222

    Agricultural compositions

    United States of America as represented by the Secretary of the Air Force Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  18. US 7015226

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted Mar 21, 2006 Β· Expires Mar 16, 2026

    expired
  19. US 7013219

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. Β· Granted Mar 14, 2006 Β· Expires Mar 9, 2026

    expired
  20. US 7012065

    Cyclosporins for the treatment of immune disorders

    Enanta Pharmaceuticals, Inc. Β· Granted Mar 14, 2006 Β· Expires Mar 9, 2026

    expired
  21. US 7011965

    Compositions and methods for stimulating wound healing and fibroblast proliferation

    Regents of the University of Minnesota Β· Granted Mar 14, 2006 Β· Expires Mar 9, 2026

    expired
  22. US 7012064

    Cyclosporins for the treatment of immune disorders

    Enanta Pharmaceuticals, Inc. Β· Granted Mar 14, 2006 Β· Expires Mar 9, 2026

    expired
  23. US 7008923

    Glycopeptide phosphonate derivatives

    Theravance, Inc. Β· Granted Mar 7, 2006 Β· Expires Mar 2, 2026

    expired
  24. US 7009044

    HCV/BVDV chimeric genomes and uses thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 7, 2006 Β· Expires Mar 2, 2026

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.